Article Versions Notes

Magez S, Li Z, Nguyen HTT, Pinto Torres JE, Van Wielendaele P, Radwanska M, Began J, Zoll S, Sterckx YG-J. The History of Anti-Trypanosome Vaccine Development Shows That Highly Immunogenic and Exposed Pathogen-Derived Antigens Are Not Necessarily Good Target Candidates: Enolase and ISG75 as Examples. Pathogens. 2021; 10(8):1050. https://doi.org/10.3390/pathogens10081050

Magez, Stefan, Zeng Li, Hang Thi Thu Nguyen, Joar Esteban Pinto Torres, Pieter Van Wielendaele, Magdalena Radwanska, Jakub Began, Sebastian Zoll, and Yann G.-J. Sterckx. 2021. "The History of Anti-Trypanosome Vaccine Development Shows That Highly Immunogenic and Exposed Pathogen-Derived Antigens Are Not Necessarily Good Target Candidates: Enolase and ISG75 as Examples" Pathogens 10, no. 8: 1050. https://doi.org/10.3390/pathogens10081050

Magez, S., Li, Z., Nguyen, H. T. T., Pinto Torres, J. E., Van Wielendaele, P., Radwanska, M., Began, J., Zoll, S., & Sterckx, Y. G.-J. (2021). The History of Anti-Trypanosome Vaccine Development Shows That Highly Immunogenic and Exposed Pathogen-Derived Antigens Are Not Necessarily Good Target Candidates: Enolase and ISG75 as Examples. Pathogens, 10(8), 1050. https://doi.org/10.3390/pathogens10081050